CYP1B1 and cancer: IHC analysis of 80 TNBC samples confirmed an association between elevated tumor cell CYP1B1 and residual cancer burden class 2/3 disease after NAC in T cell–excluded (TCE) TNBC (P < 0.01) but not in T cell–infiltrated (TCI) TNBC.